Optimizing the Recognition and Treatment of Chronic Kidney Disease (CKD) in Patients with Type 2 Diabetes (T2D): What Primary Care Clinicians Need to Know

Optimizing the Recognition and Treatment of Chronic Kidney Disease (CKD) in Patients with Type 2 Diabetes (T2D): What Primary Care Clinicians Need to Know is organized by Tarsus CNS.

Course Opens: 09/06/2024
Course Expires: 09/06/2025

Description:
Welcome to our micro-module webcast on the challenges of managing chronic kidney disease (CKD) and diabetes. After diagnosis, slowing CKD progression in type 2 diabetes (T2D) continues to pose a major challenge. Although new therapies, such as sodium-glucose cotransporter-2 (SGLT-2) inhibitors, have emerged, residual morbidity and mortality persist. Additional strategies are required to slow kidney disease progression, especially targeting inflammation and fibrosis.

This educational activity aims to bridge the gaps in recognizing and treating CKD in T2D patients among healthcare professionals, particularly primary care clinicians and others on the front lines. This micromodule webcast is designed to enhance early screening, diagnosis, and treatment of this condition.

Learning Objectives:
After completing this activity, the participant should be better able to:

• Review the importance of UACR testing, in addition to eGFR, for the screening and diagnosis of CKD in patients with T2DM
• Identify T2DM patients at risk for CKD or CKD progression based on recommended diagnostic practices
• Summarize comprehensive GDMT approaches to reduce the risk of cardiorenal adverse events in patients with T2DM and CKD
• Recognize the value of regular eGFR and UACR monitoring to guide response to current therapy in patients with CKD and T2DM in order to optimize referral and treatment.